About us
Driving advances in precision genomics to safely accelerate the identification and bioproduction of advanced cell and gene therapies.
Genomic Vision is entering an exciting phase of growth and innovation, driven by the increasing demand for sophisticated and targeted advanced therapies and a greater regulatory focus on safety on therapeutic safety.
With our innovative molecular combing technology and our experienced leadership team, we believe Genomic Vision is well-positioned to capitalize on the rapidly growing demand for highly accurate, fast, and accessible solutions for genome characterization of advanced therapies.
Our mission
At Genomic Vision, we deliver high-quality genomic solutions to improve quality control and bioproduction standards of advanced gene therapies at scale. Collaborating with our partners and customers, we strive to unlock the full potential of advanced therapies with the ultimate goal of improving the lives of patients worldwide.
We strongly believe in the endless possibilities of genomic discovery. We are motivated by the belief that every question that sparks curiosity in our minds can be answered through the exploration of genomics. This drives us to relentlessly seek answers and deliver solutions that can revolutionize healthcare.
Our team
Supervisory Board
Florence Allouche
President
Eric Edery
Vice-President
Mohammad Afshar
Member
Executive Board
Aaron Bensimon
PhD., Co-founder, CEO
Lionel Seltz
CFO
Emilie Chataignier
Member
